Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $27.37B. Across the group, the median move over the past trading day is +2.74%. Price change over the past year runs from +1.7% to +183.7% across the middle 80 percent of the group, with a median of +36.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $336.71 | +30.49% | +47.14% | +107.24% |
| 0KSX.L | Quest Diagnostics Incorporated | $243.72 | +0.48% | +42.44% | +36.94% |
| LH | Labcorp Holdings Inc. | $337.68 | +12.12% | +34.52% | +23.25% |
| 0JSY.L | Labcorp Holdings Inc. | $334.61 | +1.86% | +33.14% | +20.97% |
| DGX | Quest Diagnostics Incorporated | $244.51 | +5.46% | +41.95% | +38.70% |
| CAI | Caris Life Sciences, Inc. | $28.01 | +79.21% | +3.82% | −27.21% |
| CDNA | CareDx, Inc. | $50.80 | +39.71% | +165.41% | +298.43% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.